BMC Gastroenterol

1. XU H, Zhao H, Tao H, Liu L, et al
   Awareness, attitudes, and clinical utilization of vonoprazan for Helicobacter pylori infection and gastroesophageal reflux disease among Chinese physicians: a nationwide cross-sectional study.
   BMC Gastroenterol. 2025;25:795.
   

   >> Share

   
   
2. LONGWU X, Teng X
   A socioeconomic perspective on the global burden of gastroesophageal reflux disease (1990-2021): findings from the GBD 2021.
   BMC Gastroenterol. 2025;25:794.
   

   >> Share

   
   

   
   Helicobacter

3. MATSUMOTO C, Saito H, Nishikawa Y, Saito Y, et al
   Survey on Awareness of Helicobacter pylori and Gastric Cancer in the Japanese Population Using an Internet Survey.
   Helicobacter. 2025;30:e70089.
   

   >> Share

   
   
4. HAN Q, Zu M, Du S, Guo Y, et al
   Different Doses of Ilaprazole for Dual Therapy Versus Bismuth-Quadruple Therapy for Helicobacter pylori Infection: A Three-Arm, Randomized Clinical Trial.
   Helicobacter. 2025;30:e70086.
   

   >> Share

   
   

   
   J Ethnopharmacol

5. ZHANG T, Li H, Hao Y, Wang Y, et al
   Exploring the anti-Helicobacter pylori activity and mechanism of Shouhui Tongbian through chemical composition analysis and network pharmacology.
   J Ethnopharmacol. 2025;356:120869.
   

   >> Share

   
   

   
   Surg Endosc

6. VOLK GE, Jhang J, Ma J, Haskins IN, et al
   The association of preexisting gastroesophageal reflux disease with thirty-day intervention following sleeve gastrectomy using the ACS-MBSAQIP database.
   Surg Endosc. 2025 Nov 10. doi: 10.1007/s00464-025-12349.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share